Rethinking Clinical Trials

JULY 12, 2023

Neha Pagidipati In this Friday’s PCT Grand Rounds, Christopher Granger and Neha Pagidipati of Duke University will present “Lessons From the COORDINATE-Diabetes Trial.” Fortin, MD, Distinguished Professor of Medicine and a professor of nursing, and Dr. Pagidipati is an associate professor of medicine—both at Duke University.

Trials 130

Trials Cardiology Nurses Clinical Trials 130

Rethinking Clinical Trials

JULY 19, 2023

Distinguished Professor of Medicine Professor of Nursing Duke University Neha J. The objective of COORDINATE-Diabetes trial was to improve the implementation and adoption of these therapies by testing the impact of a clinic-level, multifaceted intervention on the prescription of 3 key groups of evidence-based therapies.

Trials 130

Trials Cardiology Medicine Nurses 130

Rethinking Clinical Trials

SEPTEMBER 22, 2022

Professor in Translational Cardiology and Pragmatic Randomized Trials. Head of Center for Translational Cardiology and Pragmatic Randomized Trials. Department of Cardiology. DANFLU-1, Pragmatic Clinical Trials. To keep the cost down, we are thinking about how to use vaccine clinics. Key Points.

Trials 130

Trials Cardiology Vaccination Vaccine 130

Drug Discovery World

OCTOBER 19, 2022

Following the news that the number of clinical trial recruiting sites in Ukraine has dropped by half since the Russian invasion, DDW’s Diana Spencer examines clinical trial data from analytics company Phesi and speaks to Dr Olena Karpenko , Clinical Research Director at Medical Center Ok!Clinic+

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

pharmaphorum

OCTOBER 2, 2020

The five new NIHR National Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical trials in the UK by offering new ways to conduct late-phase, large-scale research projects.

Clinical Trials 92

Clinical Trials Clinical Trials Life Science Clinical Research 92

XTalks

NOVEMBER 19, 2021

Cardiac biomarkers can not only serve important roles in the diagnosis, management and prognosis of cardiac diseases, but they can also be significant tools in evaluating treatments in cardiovascular (CV) clinical trials. In CV clinical trials, cardiac biomarkers are most commonly included in efficacy and safety endpoints.

Clinical Trials 98

Clinical Trials Clinical Trials Trials In-Vitro 98

Scienmag

FEBRUARY 23, 2021

UIC College of Nursing associate professor Susan Dunn explores this question as lead author of “Suicide Risk Management Protocol for a Randomized Controlled Trial of Cardiac Patients Reporting Hopelessness,” a paper published in the January/February edition of Nursing Research. Suicide is […].

Nurses 40

Nurses Research Trials Clinical Trials 40